«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:

期数:

2020年05期

页码:

643-647

栏目:

论著

出版日期:

2020-10-20

文章信息/Info

Title:

Predictive value of airway secretion amylase level to ventilator-associated pneumonia risk

作者:

张晓雪¹; 杨志旭²; 盖小荣³

100029 北京,北京中医药大学¹ 100091 北京,中国中医科学院西苑医院重症医学科² 710016 西安,西安市凤城医院呼吸科³

Author(s):

Zhang Xiaoxue¹;  Yang Zhixu²;  Gai Xiaorong³.

¹Beijing University of Chinese Medicine, Beijing 100029 China; ²Department of Critical Care Medicine, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091 China; ³Respiratory Department, Fengcheng Hospital, Xi'an 710016, China

关键词:

α-淀粉酶;  机械通气;  呼吸机相关肺炎;  预测价值

Keywords:

α-amylase;  Mechanical ventilation;  Ventilator-associated pneumonia;  Predictive value

分类号:

R563

DOI:

10.3877/cma.j.issn.1674-6902.2020.05.013

摘要:

目的 探讨支气管肺泡灌洗液α-淀粉酶在早期评估呼吸机相关肺炎(ventilator-associated pneumonia, VAP)风险的应用价值,分析导致VAP发生的危险因素。方法 选取2017年7月至2019年12月中国中医科学院西苑医院ICU收治的行气管插管机械通气的患者185例,收集患者临床资料,对所有患者在入ICU第3天行纤维支气管镜肺泡灌洗检查,检测支气管肺泡灌洗液中α-淀粉酶水平; 根据患者气管插管机械通气第3～14天内是否发生VAP分为VAP组和非VAP组,比较两组患者临床资料、α-淀粉酶水平,采用多因素logistic回归方程分析导致VAP发生的独立危险因素; 绘制受试者工作特征曲线(ROC),分析α-淀粉酶在早期预测VAP中的诊断效能。结果 185例患者共发生37例VAP,发生率为20.00%; 比较两组临床资料显示,VAP组误吸危险因素数量、GCS评分、低蛋白血症比例、机械通气时间、应用催眠镇静药和质子泵抑制剂比例以及支气管肺泡灌洗液中α-淀粉酶水平与非VAP组比较存在统计学差异(P<0.05); 多因素Logistic回归分析显示,存在误吸危险因素数量≥3个(OR=45.086)、低蛋白血症(OR=40.718)、机械通气时间越长(OR=1.464)、气管肺泡灌洗液中α-淀粉酶水平越高(OR=1.016)是导致VAP发生的独立危险因素(P<0.05); ROC曲线分析显示,α-淀粉酶水平在早期预测VAP发生的曲线下面积为0.887,高于误吸危险因素数量≥3个(AUC=0.733)、低蛋白血症(AUC=0.652)和机械通气时间(AUC=0.664),最佳截点值为580.90 U/L,预测VAP发生的敏感度为94.59%,特异度为75.00%。结论 气管插管机械通气患者入院时误吸风险数量越多、机械通气时间越长、合并低蛋白血症以及支气管肺泡灌洗液中α-淀粉酶水平越高,其发生VAP的风险就越大,支气管肺泡灌洗液中α-淀粉酶可作为评估机械通气患者VAP发生风险的新生物学标志物。

Abstract:

Objective To explore the application value of bronchoalveolar lavage fluid α-amylase in early assessment of ventilator-associated pneumonia(VAP)risk, and to analyze the risk factors leading to VAP. Methods F 185 patients who underwent tracheal intubation and mechanical ventilation who were admitted to the ICU of Xiyuan Hospital of the Chinese Academy of Chinese Medical Sciences from July 2017 to December 2019 were selected, clinical data were collected, and all patients underwent fibrobron choscope alveolar lavage examination on the third day of ICU admission. To detect the level of α-amylase in bronchoalveolar lavage fluid; According to whether VAP occurred within 3 to 14 days of endotracheal intubation mechanical ventilation, patients were divided into VAP group and non-VAP group. The clinical data and α-amylase levels of the two groups were compared. The independent risk of VAP was analyzed by multivariate logistic regression equation analysis. factor; The receiver operating characteristic curve(ROC)was drawn to analyze the diagnostic efficacy of α-amylase in the early prediction of VAP. Results A total of 37 cases of VAP occurred in 185 patients, and the incidence rate was 20.00%; comparing the clinical data of the two groups showed that the number of risk factors for aspiration of the VAP group, GCS score, hypoproteinemia rate, mechanical ventilation time, hypnotic sedation and The proportion of proton pump inhibitor and the level of α-amylase in bronchoalveolar lavage fluid were statistically different from those in non-VAP group(P<0.05); Multivariate logistic regression analysis showed that there were ≥3 risk factors for aspiration(OR=45.086), hypoproteinemia(OR=40.718), the longer the mechanical ventilation time(OR=1.464), α in tracheal alveolar lavage fluid -The higher amylase level(OR=1.016)is an independent risk factor for the occurrence of VAP(P<0.05); ROC curve analysis showed that the area under the curve of α-amylase level in the early prediction of VAP was 0.887, which was higher than the number of risk factors for aspiration ≥3(AUC=0.733), hypoproteinemia(AUC=0.652)and mechanical ventilation Time(AUC=0.664), the best cut-off value is 580.90 U/L, the sensitivity to predict the occurrence of VAP is 94.59%, and the specificity is 75.00%. Conclusion The greater the number of patients who have been admitted to the hospital for tracheal intubation mechanical ventilation, the longer the risk of aspiration, the longer the mechanical ventilation time, the combined hypoproteinemia and the higher the level of α-amylase in the bronchoalveolar lavage fluid, the greater the risk of VAP Large, α-amylase in bronchoalveolar lavage fluid can be used as a new biological marker to assess the risk of VAP in patients with mechanical ventilation.

参考文献/References:

1 McEnery T, Martin-Loeches I. Predicting ventilator-associated pneumonia[J]. Ann Transl Med, 2020, 8(11): 670.
2 郑业勤. 支气管肺泡灌洗液淀粉酶活性测定对诊断气道误吸的研究[D]. 2008.
3 陆芹芹. 吸入性肺炎相关危险因素及支气管肺泡灌洗液淀粉酶对其诊断价值的研究[D]. 2015.
4 戚良婷, 孙 昀, 赵 卉. ICU吸入性肺炎临床特点及影响因素分析[J]. 中外医学研究, 2019, 17(16): 1-4.
5 Abu-Hasan M, Elmallah M, Neal D, et al. Salivary amylase level in bronchoalveolar fluid as a marker of chronic pulmonary aspiration in children[J]. Ped Allergy Immunol Pul, 2014, 27(3): 115-119.
6 中华医学会重症医学分会. 呼吸机相关性肺炎诊断、预防和治疗指南(2013)[J]. 中华内科杂志, 2013, 52(6): 524-543.
7 高海燕, 陈希胜, 张文艳, 等. 呼吸机相关性肺炎的病原菌分布和耐药性分析[J]. 成都中医药大学学报, 2018, 41(1): 79-82.
8 周 勇. 早期不同营养方式对老年机械通气呼吸机相关性肺炎(VAP)患者的影响分析[J]. 临床肺科杂志, 2018, 23(3): 555-557.
9 张晨露, 牛小媛. 吸入性肺炎相关生物学标记物的研究进展[J]. 中华临床医师杂志(电子版), 2017, 11(4): 650-653.
10 周春燕. 呼吸机相关性肺炎与胃食管反流的相关性分析[J]. 海南医学院学报, 2016, 22(2): 141-143.
11 张 宏, 孙 辉, 欧阳文, 等. 影响COPD患者机械通气时间的相关因素分析[J]. 安徽医学, 2017, 38(1): 57-59.
12 中华医学会呼吸病学分会感染学组. 中国成人医院获得性肺炎与呼吸机相关性肺炎诊断和治疗指南(2018年版)[J]. 中华结核和呼吸杂志, 2018, 41(4): 255-280.
13 Hart R, McNeill S, Maclean S, et al. The prevalence of suspected ventilator-associated pneumonia in Scottish intensive care units[J]. J Intensive Care Soc, 2020, 21(2): 140-147.
14 Takahama A Jr, de Sousa VI, Tanaka EE, et al. Analysis of oral risk factors for ventilator-associated pneumonia in critically ill patients[J]. Clin Oral Investig, 2020, 22(1): 2-16.
15 Qu GP, Fang XQ, Xu YP, et al. Predictive value of α-amylase in tracheal aspirates for ventilator-associated pneumonia in elderly patients[J]. Clin Respir J, 2018, 12(4): 1685-1692.
16 黄妮妮, 胡美春, 韦思尊, 等. 呼吸机相关肺炎发病率及危险因素前瞻性研究[J]. 中国感染控制杂志, 2016, 15(11): 845-848.
17 许艳军, 李茂琴, 史载祥, 等. 肺泡灌洗联合抗感染治疗呼吸机相关肺炎的研究[J]. 热带医学杂志, 2016, 16(2): 206-209.
18 李文钊, 臧传刚, 李 义, 等. α-淀粉酶的研究与应用进展[J]. 当代化工, 2017, 46(11): 2292-2296.
19 刘海珊, 符照康, 李永超, 等. 生大黄灌肠辅助治疗急性胰腺炎的临床疗效及对淀粉酶与炎性炎症因子的影响[J]. 辽宁中医杂志, 2017, 44(5): 962-965.
20 刘又宁. 机械通气简史与机械通气相关肺炎[J]. 中华结核和呼吸杂志, 2019, 42(12): 881-883.
21 任占凤, 班玛措, 李 静, 等. 重症监护室呼吸机相关肺炎患者的病原菌特征与耐药性及相关因素分析[J]. 中华医院感染学杂志, 2017, 27(23): 5325-5328.
22 Samanta S, Poddar B, Azim A, et al. Significance of Mini Bronchoalveolar Lavage Fluid Amylase Level in Ventilator-Associated Pneumonia: A Prospective Observational Study[J]. Crit Care Med, 2018, 46(1): 71-78.
23 黄云峰, 周 帆, 徐晓林. 胰石蛋白在呼吸机相关性肺炎患者支气管肺泡灌洗液及呼出气冷凝液中的表达及检测价值[J]. 实用临床医药杂志, 2019, 23(11): 33-36.
24 杨 俊, 宋玉燕, 朱 涛, 等. 肺泡灌洗液中SP-A水平与ARDS病情严重程度的相关性研究[J]. 西部医学, 2019, 31(1): 56-59.
25 李杨杨, 宋 敏, 李 莉. 呼吸机相关肺炎肺泡灌洗液标志物检测的意义[J]. 临床肺科杂志, 2018, 23(11): 2028-2030.
26 刘胜华, 温建立, 邱 蓓, 等. 重症肺炎患者血清及肺泡灌洗液中炎性因子水平及临床意义[J]. 中华医院感染学杂志, 2016, 26(24): 5587-5589.
27 郑 伟, 茅一萍, 周 宏, 等. 重症监护病房呼吸机相关肺炎集束化干预效果[J]. 中国感染控制杂志, 2016, 15(1): 31-33.
28 梁添书, 邬敏志, 谭家余, 等. 中性粒细胞弹性蛋白酶对呼吸机相关性肺炎诊断及转归的评估价值[J]. 中华危重病急救医学, 2016, 28(9): 785-789.
29 贾 佳, 李 娜, 李国福, 等. 呼吸机相关性肺损伤早期生物伤的发病机制探讨[J]. 中华危重病急救医学, 2018, 30(9): 861-866.
30 Weiss CH, Moazed F, Dibardino D, et al. Bronchoalveolar lavage amylase is associated with risk factors for aspiration and predicts bacterial pneumonia[J]. Crit Care Med, 2013, 41(3): 765-773.

备注/Memo

备注/Memo:

基金项目: 中国中医科学院自由探索项目(ZZ0908040) 通信作者: 杨志旭, Email: yangzhixu@sohu.com

常用功能

更新日期/Last Update: 2020-10-20